Cargando…
Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations
Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plas...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265332/ https://www.ncbi.nlm.nih.gov/pubmed/35805133 http://dx.doi.org/10.3390/cells11132046 |
_version_ | 1784743187337707520 |
---|---|
author | Pardo-Camacho, Cristina Ganda Mall, John-Peter Martínez, Cristina Pigrau, Marc Expósito, Elba Albert-Bayo, Mercé Melón-Ardanaz, Elisa Nieto, Adoración Rodiño-Janeiro, Bruno Fortea, Marina Guagnozzi, Danila Rodriguez-Urrutia, Amanda de Torres, Inés Santos-Briones, Ignacio Azpiroz, Fernando Lobo, Beatriz Alonso-Cotoner, Carmen Santos, Javier González-Castro, Ana M. Vicario, Maria |
author_facet | Pardo-Camacho, Cristina Ganda Mall, John-Peter Martínez, Cristina Pigrau, Marc Expósito, Elba Albert-Bayo, Mercé Melón-Ardanaz, Elisa Nieto, Adoración Rodiño-Janeiro, Bruno Fortea, Marina Guagnozzi, Danila Rodriguez-Urrutia, Amanda de Torres, Inés Santos-Briones, Ignacio Azpiroz, Fernando Lobo, Beatriz Alonso-Cotoner, Carmen Santos, Javier González-Castro, Ana M. Vicario, Maria |
author_sort | Pardo-Camacho, Cristina |
collection | PubMed |
description | Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology. |
format | Online Article Text |
id | pubmed-9265332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92653322022-07-09 Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations Pardo-Camacho, Cristina Ganda Mall, John-Peter Martínez, Cristina Pigrau, Marc Expósito, Elba Albert-Bayo, Mercé Melón-Ardanaz, Elisa Nieto, Adoración Rodiño-Janeiro, Bruno Fortea, Marina Guagnozzi, Danila Rodriguez-Urrutia, Amanda de Torres, Inés Santos-Briones, Ignacio Azpiroz, Fernando Lobo, Beatriz Alonso-Cotoner, Carmen Santos, Javier González-Castro, Ana M. Vicario, Maria Cells Article Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology. MDPI 2022-06-28 /pmc/articles/PMC9265332/ /pubmed/35805133 http://dx.doi.org/10.3390/cells11132046 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pardo-Camacho, Cristina Ganda Mall, John-Peter Martínez, Cristina Pigrau, Marc Expósito, Elba Albert-Bayo, Mercé Melón-Ardanaz, Elisa Nieto, Adoración Rodiño-Janeiro, Bruno Fortea, Marina Guagnozzi, Danila Rodriguez-Urrutia, Amanda de Torres, Inés Santos-Briones, Ignacio Azpiroz, Fernando Lobo, Beatriz Alonso-Cotoner, Carmen Santos, Javier González-Castro, Ana M. Vicario, Maria Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations |
title | Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations |
title_full | Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations |
title_fullStr | Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations |
title_full_unstemmed | Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations |
title_short | Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations |
title_sort | mucosal plasma cell activation and proximity to nerve fibres are associated with glycocalyx reduction in diarrhoea-predominant irritable bowel syndrome: jejunal barrier alterations underlying clinical manifestations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265332/ https://www.ncbi.nlm.nih.gov/pubmed/35805133 http://dx.doi.org/10.3390/cells11132046 |
work_keys_str_mv | AT pardocamachocristina mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT gandamalljohnpeter mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT martinezcristina mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT pigraumarc mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT expositoelba mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT albertbayomerce mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT melonardanazelisa mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT nietoadoracion mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT rodinojaneirobruno mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT forteamarina mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT guagnozzidanila mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT rodriguezurrutiaamanda mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT detorresines mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT santosbrionesignacio mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT azpirozfernando mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT lobobeatriz mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT alonsocotonercarmen mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT santosjavier mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT gonzalezcastroanam mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations AT vicariomaria mucosalplasmacellactivationandproximitytonervefibresareassociatedwithglycocalyxreductionindiarrhoeapredominantirritablebowelsyndromejejunalbarrieralterationsunderlyingclinicalmanifestations |